<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hegazy A</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Deutsches Zentrum f?r Infektionsforschung</funding><funding>National Research Centre</funding><pagination>41212-41223</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9670689</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(45)</volume><pubmed_abstract>The evolution of drug-resistant viral strains following natural acquisition of resistance mutations is a major obstacle to antiviral therapy. Besides the improper prescription of the currently licensed anti-influenza medications, M2-blockers and neuraminidase inhibitors, to control poultry outbreaks/infections potentiates the emergence of drug-resistant influenza variants. Therefore, there is always a necessity to find out new alternatives with potent activity and high safety. Plant extracts and plant-based chemicals represent a historical antiviral resource with remarkable safety &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i> to control the emerging and remerging health threats caused by viral infections. Herein, a panel of purified plant extracts and subsequent plant-derived chemicals were evaluated</pubmed_abstract><journal>ACS omega</journal><pubmed_title>Robust Antiviral Activity of Santonica Flower Extract (&lt;i>Artemisia cina&lt;/i>) against Avian and Human Influenza A Viruses: &lt;i>In Vitro&lt;/i> and Chemoinformatic Studies.</pubmed_title><pmcid>PMC9670689</pmcid><funding_grant_id>12010126</funding_grant_id><funding_grant_id>TT110801</funding_grant_id><funding_grant_id>SFB-TR 84</funding_grant_id><pubmed_authors>Mraheil MA</pubmed_authors><pubmed_authors>Shehata M</pubmed_authors><pubmed_authors>Mostafa A</pubmed_authors><pubmed_authors>Hegazy A</pubmed_authors><pubmed_authors>Yahya G</pubmed_authors><pubmed_authors>El-Shazly AM</pubmed_authors><pubmed_authors>Nasr NF</pubmed_authors><pubmed_authors>El-Halawany AM</pubmed_authors><pubmed_authors>Abo Shama NM</pubmed_authors><pubmed_authors>Ali MA</pubmed_authors><pubmed_authors>Mostafa I</pubmed_authors><pubmed_authors>Elshaier YAMM</pubmed_authors><pubmed_authors>Mahmoud SH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Robust Antiviral Activity of Santonica Flower Extract (&lt;i>Artemisia cina&lt;/i>) against Avian and Human Influenza A Viruses: &lt;i>In Vitro&lt;/i> and Chemoinformatic Studies.</name><description>The evolution of drug-resistant viral strains following natural acquisition of resistance mutations is a major obstacle to antiviral therapy. Besides the improper prescription of the currently licensed anti-influenza medications, M2-blockers and neuraminidase inhibitors, to control poultry outbreaks/infections potentiates the emergence of drug-resistant influenza variants. Therefore, there is always a necessity to find out new alternatives with potent activity and high safety. Plant extracts and plant-based chemicals represent a historical antiviral resource with remarkable safety &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i> to control the emerging and remerging health threats caused by viral infections. Herein, a panel of purified plant extracts and subsequent plant-derived chemicals were evaluated</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-05-31T23:32:31.612Z</modification><creation>2025-05-31T23:32:31.612Z</creation></dates><accession>S-EPMC9670689</accession><cross_references><pubmed>36406485</pubmed><doi>10.1021/acsomega.2c04867</doi></cross_references></HashMap>